PEG-OCL micelles for quercetin solubilization and inhibition of cancer cell growth

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 2, 2011, Pages 268-275

  Khonkarn, Ruttiros ^a   Mankhetkorn, Samlee ^a   Hennink, Wim E ^b   Okonogi, Siriporn ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL DERIVATIVE; POLY(ETHYLENE GLYCOL) B OLIGO(EPSILON CAPROLACTONE); QUERCETIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SOLUBILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICELLE; PARTICLE SIZE;

EID: 80054974549     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.04.011     Document Type: Article

References (42)

1. V.J. Mohanraj, Y. Chen, Nanoparticle - a review, Trop. J. Pharm. Res. 5 (2006) 561-573.
2. S.A. Agnihotri, N.N. Mallikarjuna, T.M. Aminabhavi, Recent advances on chitosan-based micro- and nanoparticles in drug delivery, J. Controlled Release 100 (2004) 5-28. (Pubitemid 39445982)
3. S.K. Sahoo, V. Labhasetwar, Nanotech approaches to drug delivery and imaging, Drug Discov. Today 8 (2003) 1112-1120. (Pubitemid 37547917)
4. K. Hanna, R. Denoyel, I. Beurroies, J.P. Dubs, Solubilization of pentachlorophenol in micelles and confined surfactant phases, Colloids Surf. A 254 (2005) 231-239. (Pubitemid 40164849)
5. S.S. Shah, M. Ali Awan, M. Ashraf, S.A. Idris, Solubilization of phenol and benzyl alcohol by cationic and anionic surfactant micelles, Colloids Surf. A 105 (1995) 319-323.
6. S.B. La, T. Okano, K. Kataoka, Preparation and characterization of the micelleforming polymeric drug: indomethacin-incorporated poly(ethylene oxide)-poly(b-benzyl-L-aspartate) block copolymer micelles, J. Pharm. Sci. 85 (1996) 85-90. (Pubitemid 26029075)
7. Y. Yamamoto, K. Yasugi, A. Harada, Y. Nagasaki, K. Kataoka, Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles in aqueous milieu, J. Controlled Release 82 (2002) 359-371. (Pubitemid 34880190)
8. O. Molavi, Z. Ma, A. Mahmud, A. Alshamsan, J. Samuel, R. Lai, G.S. Kwon, A. Lavasanifar, Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors, Int. J. Pharm. 347 (2008) 118-127. (Pubitemid 350180319)
9. N. Nishiyama, K. Kataoka, Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery, Pharmacol. Ther. 112 (2006) 630-648. (Pubitemid 44592613)
10. M.C. Jones, J.C. Leroux, Polymeric micelles - a new generation of colloidal drug carriers, Eur. J. Pharm. Biopharm. 48 (1999) 101-111.
11. C. Oerlemans, W. Bult, M. Bos, G. Storm, J. Frank, W. Nijsen, W.E. Hennink, Polymeric micelles in anticancer therapy: targeting, imaging and triggered release, Pharm. Res. 27 (2010) 2569-2589.
12. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics; a review, J. Controlled Release 65 (2000) 271-284. (Pubitemid 30122932)
13. H. Maeda, Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects, Bioconjugate Chem. 21 (2010) 797-802.
14. J.C. Lee, J. Kim, J.K. Park, G.H. Chung, Y.S. Jang, The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis, Exp. Cell Res. 291 (2003) 386-397. (Pubitemid 37485726)
15. K. Horvathova, I. Chalupa, L. Šebova, D. Tothova, A. Vachalkova, Protective effect of quercetin and luteolin in human melanoma HMB-2 cells, Mutat. Res., Genet. Toxicol. Environ. Mutagen. 565 (2005) 105-112. (Pubitemid 40127572)
16. S. Dechsupa, S. Kothan, S. Vergote, G. Leger, A. Martineau, S. Beranger, R. Kosanlavit, J.L. Moretti, S. Mankhetkorn, Quercetin, siamois 1 and siamois 2 induce apoptosis in human breast cancer MDA-MB-435 cells xenograft in vivo, Cancer Biol. Ther. 6 (2007) 48-53.
17. T.J. Lee, O.H. Kim, Y.H. Kim, J.H. Lim, S. Kim, J.W. Park, T.K. Kwon, Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells, Cancer Lett. 240 (2006) 234-242. (Pubitemid 44109922)
18. A.A. Dihal, R.A. Woutersen, B.V. Ommen, I.M.C.M. Rietjens, R.H. Stierum, Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line caco-2, Cancer Lett. 238 (2006) 248-259. (Pubitemid 43867910)
19. J. Jakubowicz-Gil, R. Paduch, T. Piersiak, K. Glowniak, A. Gawron, M. Kandefer-Szerszen, The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells, Biochem. Pharmacol. 69 (2005) 1343-1350.
20. W.F. Tan, L.P. Lin, M.H. Li, Y.X. Zhang, Y.G. Tong, D. Xiao, J. Ding, Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential, Eur. J. Pharmacol. 459 (2003) 255-262. (Pubitemid 36078329)
21. M. Tungjai, W. Poompimon, C. Loetchutinat, S. Kothan, N. Dechsupa, M. Mankhetkorn, Spectrophotometric characterization of behavior and the predominant species of flavonoids in physiological buffer: determination of solubility, lipophilicity and anticancer efficacy, Open Drug Deliv. J. 2 (2008) 10-19.
22. P.C.H. Hollman, J.M.P. van Trijp, M.J.B. Mengelers, J.H.M. de Vries, M.B. Katan, Bioavailability of the dietary antioxidant flavonol quercetin in man, Cancer Lett. 114 (1997) 139-140. (Pubitemid 27140094)
23. M.G. Carstens, J.J.L. Bevernage, C.F. van Nostrum, M.J. van Steenbergen, F.M. Flesch, R. Verrijk, L.G.J. de Leede, D.J.A. Crommelin, W.E. Hennink, Small oligomeric micelles based on end group modified mPEG-oligocaprolactone with monodisperse hydrophobic blocks, Macromolecules 40 (2007) 116-122. (Pubitemid 46144458)
24. M.G. Carstens, P.H.J.L.F. de Jong, C.F. van Nostrum, J. Kemmink, R. Verrijk, L.G.J. de Leede, D.J.A. Crommelin, W.E. Hennink, The effect of core composition in biodegradable oligomeric micelles as taxane formulations, Eur. J. Pharm. Biopharm. 68 (2008) 596-606. (Pubitemid 351318214)
25. M.G. Carstens, C.F. van Nostrum, R. Verrijk, L.G.J. de Leede, D.J.A. Crommelin, W.E. Hennink, A mechanistic study on the chemical and enzymatic degradation of PEG-oligo(e-caprolactone) micelles, J. Pharm. Sci. 97 (2007) 506-518.
26. M. Jiménez, F. García-Carmona, Oxidation of the flavonol quercetin by polyphenol oxidase, J. Agric. Food Chem. 47 (1999) 56-60. (Pubitemid 29179623)
27. J.R. Tennant, Evaluation of the trypan blue technique for determination of cell viability, Transplantation 2 (1964) 685-694.
28. M.C. Alley, D.A. Scudiero, A. Monks, Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay, Cancer Res. 48 (1988) 589-601. (Pubitemid 18056527)
29. W. Suttana, Ph.D. dissertation, Chiang Mai University, Chiang Mai, Thailand, 2009.
30. H. Maeda, Nitroglycerin enhances vascular blood flow and drug delivery in hypoxic tumor tissues: analogy between angina pectoris and solid tumors and enhancement of the EPR effect, J. Controlled Release 142 (2010) 296-298.
31. S. Nie, Y. Xing, G.J. Kim, J.W. Simons, Nanotechnology applications in cancer, Annu. Rev. Biomed. Eng. 9 (2007) 257-288. (Pubitemid 350246658)
32. Y. Li, K. Xiao, J. Luo, J. Lee, S. Pan, K.S. Lam, A novel size-tunable nanocarrier system for targeted anticancer drug delivery, J. Controlled Release 144 (2010) 314-323.
33. Y. Takakura, R.I. Mahato, M. Hashida, Extravasation of macromolecules, Adv. Drug Deliv. Rev. 34 (1998) 93-108. (Pubitemid 28464480)
34. A.N. Lukyanov, Z. Gao, L. Mazzola, V.P. Torchilin, Polyethylene glycol-diacyl lipid micelles demonstrate increased accumulation in subcutaneous tumors in mice, Pharm. Res. 19 (2002) 1424-1429. (Pubitemid 35266545)
35. C. Lu, L. Liu, S.-R. Guo, Y. Zhang, Z. Li, J. Gu, Micellization and gelation of aqueous solutions of star-shaped PEG-PCL block copolymers consisting of branched 4-arm poly(ethylene glycol) and polycaprolactone blocks, Eur. Polym. J. 43 (2007) 1857-1865. (Pubitemid 46660868)
36. J. Liu, F. Zeng, C. Allen, In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration, Eur. J. Pharm. Biopharm. 65 (2007) 309-319.
37. N. Rapoport, A.P. Marin, A.A. Timoshin, Effect of a polymeric surfactant on electron transport in HL-60 cells, Arch. Biochem. Biophys. 384 (2000) 100-108.
38. A.V. Kabanov, E.V. Batrakova, V.Y. Alakhov, Pluronic block copolymers for overcoming drug resistance in cancer, Adv. Drug Deliver. Rev. 54 (2002) 759-779. (Pubitemid 35247525)
39. E.S. Lee, K. Na, Y.H. Bae, Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor, J. Controlled Release 103 (2005) 405-418. (Pubitemid 40342538)
40. J.A. Choi, J.Y. Kim, J.Y. Lee, C.M. Kang, H.J. Kwon, Y.D. Yoo, et al., Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin, Int. J. Oncol. 19 (2001) 837-844.
41. N. Hosokawa, Y. Hosokawa, T. Sakai, M. Yoshida, N. Marui, H. Nishino, et al., Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein in human colon cancer cells, Int. J. Cancer 45 (1990) 1119-1124. (Pubitemid 20201584)
42. M. Yoshida, M. Yamamoto, T. Nikaido, Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle, Cancer Res. 52 (1992) 6676-6681.